Search Medical Condition
Please enter condition
Please choose location from dropdown

Chang Chun, China Clinical Trials

A listing of Chang Chun, China clinical trials actively recruiting patients volunteers.

Found (205) clinical trials

Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis

This is a 6 month study investigating the effectiveness and safety of tofacitinib in treating signs and symptoms and improving physical function in Chinese patients with active psoriatic arthritis and had inadequate response to a conventional synthetic disease modifying anti-rheumatic drug. This is a China alone study.

Phase

0.0 miles

Learn More »

Predictive Value of Inflammatory Biomarkers and FEV1 for COPD

This is a multi-center, prospective, cohort study. A total of 10,000 subjects aged 4075 without history of lung disease will be recruited and followed for 3 years. The Department of Respiratory and Critical Care of Peking University First Hospital is responsible for this research. Other 9 units participating in the …

Phase N/A

0.0 miles

Learn More »

Coil System(Ton-bridgeMT) for Endovascular Embolization of Cranial Aneurysms

The study is a prospective, multi-center, randomized, open, parallel positive control, non-inferiority trial. Patients are randomized 1:1 to either Coil System(Ton-bridgeMT) or Axium Detachable Coil(Medtronic). The purpose of this study is to assess the safety and effectiveness of the Coil System(Ton-bridgeMT) in the treatment of intracranial aneurysms.

Phase N/A

0.0 miles

Learn More »

Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy

To compare and evaluate the efficacy and safety of Liporaxel solution (oral paclitaxel) and Taxol (IV paclitaxel) on recurrent or metastatic breast cancer.

Phase

0.0 miles

Learn More »

A Multi-center Prospective Cohort Study Based on Peritoneal Dialysis Telemedicine-based Management Platform

The growing number of patients with ESRD leads to an increasing medical burden all around the world. Patients on PD have a similar long-term survival rate as patients on hemodialysis, with a much lower cost of medical resources. Therefore, increasing the percentage of patients on PD may relieve the increasing …

Phase N/A

0.0 miles

Learn More »

Survival Study of the Recombinant Human Neuregulin-1 in Subjects With Chronic Heart Failure.

The mortality of chronic heart failure patients remains high, in spite of current treatment. RhNRG-1(recombinant human neuregulin-1)directly work on the cardiomyocyte and restored the normal structure and function of it. Both the preclinical trials, phase II clinical trials and already completed phase III clinical trails have confirmed that rhNRG-1 effectively …

Phase

0.0 miles

Learn More »

Syndrome Differentiation in the Management of Chronic Stable Coronary Artery Disease (SCAD) to Improve Quality

Chronic stable coronary artery disease (SCAD) is a general term for all kinds of coronary artery disease (CAD) which includes patients with chronic stable angina, oldmyocardial infarctions and also stable condition after revascularization (i.e percutaneous coronary intervention PCI, coronary artery bypass graft CABG). According to 2012 American Heart Association/American College …

Phase N/A

0.0 miles

Learn More »

INternational ORthopaedic MUlticenter Study in Fracture Care (INORMUS)

Number of Participants: 40,000 Primary Research Objectives: To determine among adult individuals admitted to hospital with musculoskeletal trauma (e.g. fractures or dislocations): The incidence of major complications (mortality, re-operation and infection) as a composite outcome and as individual components within 30 days post-hospital admission. The factors (system and patient variables) …

Phase N/A

0.0 miles

Learn More »

Dual TORC1/TORC2 Inhibitor ATG-008 (CC-223) in HBV Positive Advanced Hepatocellular Carcinoma (HCC) Subjects

This is an Asian multi-regional clinical trial (MRCT) in which ATG-008 will be administered orally to hepatitis B positive (HBV+) HCC subjects who have received at least one prior line of systemic therapy. It is designed as an open-label phase 2 trial evaluating the pharmacokinetics (PK), safety, tolerability and efficacy …

Phase

0.0 miles

Learn More »

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus

The reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).

Phase

0.0 miles

Learn More »